Global Companion Diagnostics Market to Record Significant Growth as Cancer Cases & Mortalities Rise

1
Global Companion Diagnostics Market to Record
Significant Growth as Cancer Cases Mortalities
Rise According to a new market research report
launched by Inkwood Research, the Global
Companion Diagnostics Market is set to grow with
a CAGR of 13.29 and generate a revenue of
15441.90 million during the forecast period of
2022 to 2030. Browse 55 market data Tables and 49
figures spread over 230 Pages, along with an
in-depth analysis of the Global Companion
Diagnostics Market by Technology, Indication,
Products Services, End- User, by
Geography This insightful market research report
by Inkwood Research focuses on market trends,
leading players, supply chain trends,
technological innovations, key developments, and
future strategies. The report covers all the
aspects of this comprehensive market by assessing
major geographies and is a valuable asset for the
existing players, new entrants, and future
investors. The study presents a detailed market
analysis, with inputs derived from industry
professionals across the value chain.
Global Companion Diagnostics Market Scenario The
global companion diagnostics market growth is
driven by the rising popularity of precision
medicine, the increasing number of adverse drug
reactions, and the surging number of cancer cases
and mortalities. As per the World Health
Organization (WHO), following cardiovascular
illnesses, cancer is the
second-leading cause of mortality globally,
accounting for nearly one in six fatalities.
Furthermore,
2

• an estimated 10 million people died because of
  cancer-related causes in the year 2020. Hence,
  the increasing prevalence of cancer has bolstered
  the development of treatment strategies as well
  as medicine over the years.
• On the other hand, owing to the increasing
  adoption of unhealthy lifestyles in emerging
  countries, such as poor diet, smoking, and
  physical inactivity, the future impact of cancer
  is expected to be higher. While researchers
  continue to push the limit in terms of pursuing
  appropriate treatments, the concept of one
  medicine for all diseases has paved the way for
  many medicines for one disease. As a result,
  precision medicine has significantly gained
  ground, thereby fueling the demand and adoption
  of companion diagnostics over the forecasting
  period.
• The Global Companion Diagnostics Market report
  provides data tables and includes charts and
  graphs for visual analysis.
• Request Free Sample Report for Global Companion
  Diagnostics Market by Products Services,
  Technology, Indication, End-User, by Geography
  https//www.inkwoodresearch.com/reports/companion-
  diagnostics-market/request-free-sample
• Market Segmentation Market by Indication
• Oncology
• Neurology
• Infectious Disease
• Other Indications
• Market by Technology
• In Situ Hybridization
• Polymerase Chain Reaction
• Immunohistochemistry
• Next Generation Sequencing
• Other Technologies
• Market by End-User

- Market forecasts till 2030, using estimated
market values as the base numbers
3

• Key market trends across the business segments,
  regions, and countries
• Key developments and strategies observed in the
  market
• Market dynamics such as drivers, restraints,
  opportunities, and other trends
• In-depth company profiles of key players and
  upcoming prominent players
• Growth prospects among the emerging nations
  through 2030
• Companies Profiled
• BIOMERIEUX SA
• ROCHE DIAGNOSTICS
• DANAHER CORPORATION
• ILLUMINA INC
• ABBOTT LABORATORIES
• AGILENT
• ALAMC GROUP
• GE HEALTHCARE
• ARUP LABORATORIES
• BIOCARTIS
• MYRIAD GENETICS INC

4
(No Transcript)